Waters Introduces Faster, Reliable and Automated Solution for Mass and…

Waters Corporation (NYSE:WAT) today introduced new software and analytical columns to aid biomolecule drug discovery and development. The new Waters™ Intact Mass app on waters_connect™ allows scientists using the BioAccord™ LC-MS System to confirm the mass of biomolecules and impurities made by synthetic or recombinant processes nearly twice as fast as other commercially available options.[i] “Acquiring mass and purity data of biomolecules is time consuming. Skilled analysis of comple...